|

11-04-2009, 06:20 AM
|
|
Senior Member
|
|
Join Date: Oct 2007
243 posts, read 167,119 times
Reputation: 136
|
|
|
What a MAN...............NOT
With a little restraint he could have saved a whole lot of jobs.
|
|

11-04-2009, 06:32 AM
|
|
Member
|
|
Join Date: Nov 2009
45 posts, read 9,666 times
Reputation: 24
|
|
|
What is the big deal about this? As CEO of J&J, I'm sure he already had millions of dollars tucked away. Whether or not 8,000 employees were laid off has nothing to do with him buying an expensive home with money he already has.
|
|

11-04-2009, 06:55 AM
|
|
Senior Member
|
|
Join Date: May 2008
Location: NJ
706 posts, read 293,031 times
Reputation: 433
|
|
good for him!
Purchases take place up and down the economic spectrum despite the turmoil of life.
What he should do is manage the company better. He shouldn't take his money and hand it out as charity. It is a case of mediocrity appearing to be the leading edge of productivity.
It is dismaying that J&J, as a representataive of the pharma group, continues to go down the path of recycled leadership, obscured vision and a grand startegy to lead the pharma pack in a race for mediocrity.
It is dismaying that J&J, as well as all pharma, squanders the human and financial resources available to be more productive than their management has the vision to achieve. Make no mistake, the contributions of pharma have been a blessing to our society. The saddness is the loss of what could be accomplished by organizations with visionary management.
As Carl Icahn once wrote, there is a reverse evolution of management where a poor leader selects a manager as skilled or less skilled which fosters a downward spiral of a company's leadership.
The industry continues to recycle rejected leaders whose failed policies and actions made them persona non grata in other companies. Now J&J, Merck, etc., gets to recycle hand me down leaders whose focus is to apply their signature to the 'new' company. The main goal of the work force becomes a game of survival in this recycled environment. The business goals becomes secondary to survival skills of not necessarily the best employees.
Imagine the frustration of pulling out meeting notes from 15 years ago which reflect the resolution of same agrument taking place today with a new set of faces.
Imagine new leaders placed to justify their rise to power whose ego and inexperience results in a 30K $$ loss on a cancer project start up procedure despite the protestations of the entire team. Hold this in contrast to a local women's club raising $1,500 for breast cancer research. The managerial waste is colossal and becomes the hidden cause to lay people off and send jobs to China and India.
Pharma is a classic case of history repeating itself to infinity with serendipitious benefits occassionally flying from the waste. Benefits so great Bill Weldon gets the money he does.
|
|

11-04-2009, 08:20 AM
|
|
Senior Member
|
|
Join Date: Jan 2007
763 posts, read 321,212 times
Reputation: 170
|
|
|
Obviously if the company is laying off people they are short on revenue meaning someone up top in management missed their goal meaning they shouldn't be getting sky high bonuses. Yet they still get the sky high bonuses and employees get layed off to make up the budget.
|
|

11-04-2009, 10:35 AM
|
|
Live Free or Die!!!
|
|
Join Date: Mar 2008
Location: PA
1,855 posts, read 602,078 times
Reputation: 468
|
|
Quote:
Originally Posted by Kracer
Purchases take place up and down the economic spectrum despite the turmoil of life.
What he should do is manage the company better. He shouldn't take his money and hand it out as charity. It is a case of mediocrity appearing to be the leading edge of productivity.
It is dismaying that J&J, as a representataive of the pharma group, continues to go down the path of recycled leadership, obscured vision and a grand startegy to lead the pharma pack in a race for mediocrity.
It is dismaying that J&J, as well as all pharma, squanders the human and financial resources available to be more productive than their management has the vision to achieve. Make no mistake, the contributions of pharma have been a blessing to our society. The saddness is the loss of what could be accomplished by organizations with visionary management.
As Carl Icahn once wrote, there is a reverse evolution of management where a poor leader selects a manager as skilled or less skilled which fosters a downward spiral of a company's leadership.
The industry continues to recycle rejected leaders whose failed policies and actions made them persona non grata in other companies. Now J&J, Merck, etc., gets to recycle hand me down leaders whose focus is to apply their signature to the 'new' company. The main goal of the work force becomes a game of survival in this recycled environment. The business goals becomes secondary to survival skills of not necessarily the best employees.
Imagine the frustration of pulling out meeting notes from 15 years ago which reflect the resolution of same agrument taking place today with a new set of faces.
Imagine new leaders placed to justify their rise to power whose ego and inexperience results in a 30K $$ loss on a cancer project start up procedure despite the protestations of the entire team. Hold this in contrast to a local women's club raising $1,500 for breast cancer research. The managerial waste is colossal and becomes the hidden cause to lay people off and send jobs to China and India.
Pharma is a classic case of history repeating itself to infinity with serendipitious benefits occassionally flying from the waste. Benefits so great Bill Weldon gets the money he does.
|
Hmmm sounds like you worked for J&J and or still do.
Enjoying that outsoucring are we. :-)
|
Please register to post and access all features of our very popular forum. It is free and quick.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.
|
|